These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1445954)

  • 1. Central anticholinergic syndrome in a pediatric patient following transdermal scopolamine patch placement.
    Holland MS
    Nurse Anesth; 1992 Sep; 3(3):121-4. PubMed ID: 1445954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nausea prophylaxis using transdermal scopolamine in the setting of patient-controlled analgesia.
    Harris SN; Sevarino FB; Sinatra RS; Preble L; O'Connor TZ; Silverman DG
    Obstet Gynecol; 1991 Oct; 78(4):673-7. PubMed ID: 1923171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine for prevention of postoperative nausea in gynecologic laparoscopy, a randomized trial.
    Einarsson JI; Audbergsson BO; Thorsteinsson A
    J Minim Invasive Gynecol; 2008; 15(1):26-31. PubMed ID: 18262140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery.
    Sah N; Ramesh V; Kaul B; Dalby P; Shestak K; Vallejo MC
    J Clin Anesth; 2009 Jun; 21(4):249-52. PubMed ID: 19502023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative transdermal scopolamine does not reduce the level of nausea and frequency of vomiting after laparoscopic cholecystectomy.
    Sohi HS; Heipel J; Inman KJ; Chinnick B; Cunningham DG; Holliday RL; Girotti MJ
    Can J Surg; 1994 Aug; 37(4):307-12. PubMed ID: 8055388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
    Patel PN; Ezzo DC
    Am J Health Syst Pharm; 2009 Nov; 66(22):2024-6. PubMed ID: 19890085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal scopolamine for prevention of intrathecal morphine-induced nausea and vomiting after cesarean delivery.
    Harnett MJ; O'Rourke N; Walsh M; Carabuena JM; Segal S
    Anesth Analg; 2007 Sep; 105(3):764-9. PubMed ID: 17717237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transderm scopolamine for the control of perioperative nausea.
    Stromberg BV; Reines DH; Ackerly J
    Am Surg; 1991 Nov; 57(11):712-5. PubMed ID: 1746779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy.
    Bailey PL; Streisand JB; Pace NL; Bubbers SJ; East KA; Mulder S; Stanley TH
    Anesthesiology; 1990 Jun; 72(6):977-80. PubMed ID: 2140929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible central anticholinergic syndrome following transdermal scopolamine in an ambulatory surgery patient.
    Norton JA; Khabiri B; Arbona FL; Kover AJ
    Can J Anaesth; 2011 Dec; 58(12):1149-50. PubMed ID: 21989550
    [No Abstract]   [Full Text] [Related]  

  • 12. Prochlorperazine and transdermal scopolamine added to a metoclopramide antiemetic regimen. A controlled comparison.
    Malone JM; Christensen CW; Yashinsky D; Malviya VK; Deppe G
    J Reprod Med; 1990 Oct; 35(10):932-4. PubMed ID: 2246759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal scopolamine and postoperative nausea and vomiting.
    Hendley BJ
    Anesthesiology; 1991 Jan; 74(1):198-9. PubMed ID: 1986653
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. A prospective randomized study of metoclopramide and transdermal hyoscine.
    Thune A; Appelgren L; Haglind E
    Eur J Surg; 1995 Apr; 161(4):265-8. PubMed ID: 7612769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal scopolamine patch with odansetron for the control of nausea after uterine artery embolization compared with odansetron alone: results of a randomized placebo-controlled trial.
    Lee JS; Costantino M; McCullough MF; Lee JB; Jones MM; Carter EA; Spies JB
    J Vasc Interv Radiol; 2010 Jul; 21(7):1018-23. PubMed ID: 20537558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia associated with central anticholinergic syndrome caused by a transdermal hyoscine patch in a child with cerebral palsy.
    Frampton A; Spinks J
    Emerg Med J; 2005 Sep; 22(9):678-9. PubMed ID: 16113205
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of postoperative nausea and vomiting with transdermal hyoscine in children using patient-controlled analgesia.
    Doyle E; Byers G; McNicol LR; Morton NS
    Br J Anaesth; 1994 Jan; 72(1):72-6. PubMed ID: 8110556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which is better--retroperitoneoscopic or laparoscopic dismembered pyeloplasty in children?
    Canon SJ; Jayanthi VR; Lowe GJ
    J Urol; 2007 Oct; 178(4 Pt 2):1791-5; discussion 1795. PubMed ID: 17707427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of transdermal scopolamine.
    Wilkinson JA
    J Emerg Med; 1987; 5(5):389-92. PubMed ID: 3668203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
    Björk M; Wettergren B
    Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.